06.01.2013 Views

Opera ve Emulsifica on of Perfluorocarbon Liquid associated with 23

Opera ve Emulsifica on of Perfluorocarbon Liquid associated with 23

Opera ve Emulsifica on of Perfluorocarbon Liquid associated with 23

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Intra-­‐<str<strong>on</strong>g>Opera</str<strong>on</strong>g>*<str<strong>on</strong>g>ve</str<strong>on</strong>g> <str<strong>on</strong>g>Emulsifica</str<strong>on</strong>g>*<strong>on</strong> <strong>of</strong><br />

Perfluorocarb<strong>on</strong> <strong>Liquid</strong> <strong>associated</strong> <strong>with</strong> <strong>23</strong>-­‐<br />

Guage Vitrectomy<br />

Roxane J. Hillier FRCOphth, David T. W<strong>on</strong>g FRCSC<br />

St Michael’s Hospital, Tor<strong>on</strong>to, Canada<br />

C<strong>on</strong>tact: roxanehillier@gmail.com


Introduc*<strong>on</strong> & purpose<br />

• C<strong>on</strong>temporary <strong>23</strong>-­‐guage vitrectomy systems <strong>of</strong>fer enhanced efficiency <strong>of</strong><br />

vitreous clearance and beLer intra-­‐operaM<str<strong>on</strong>g>ve</str<strong>on</strong>g> intra-­‐ocular pressure (IOP)<br />

c<strong>on</strong>trol. Key advances ha<str<strong>on</strong>g>ve</str<strong>on</strong>g> been made in terms <strong>of</strong> trocar cannula design and<br />

IOP regulated infusi<strong>on</strong> technology. Howe<str<strong>on</strong>g>ve</str<strong>on</strong>g>r, <strong>with</strong>out appropriate<br />

modificaM<strong>on</strong>s to surgical technique, these features may predispose to intra-­‐<br />

operaM<str<strong>on</strong>g>ve</str<strong>on</strong>g> perfluorocarb<strong>on</strong> liquid emulsificaM<strong>on</strong> and other surgical difficulMes.<br />

• The purpose <strong>of</strong> this poster is to illustrate a no<str<strong>on</strong>g>ve</str<strong>on</strong>g>l intra-­‐operaM<str<strong>on</strong>g>ve</str<strong>on</strong>g> challenge and<br />

suggest ways to avoid it.<br />

Methods<br />

• We report <strong>on</strong> our pers<strong>on</strong>al experience using the Alc<strong>on</strong> CONSTELLATION®<br />

Visi<strong>on</strong> System and Alc<strong>on</strong> <strong>23</strong>G standard (val<str<strong>on</strong>g>ve</str<strong>on</strong>g>less) and val<str<strong>on</strong>g>ve</str<strong>on</strong>g>d cannula entry<br />

systems.


Results<br />

Standard (val<str<strong>on</strong>g>ve</str<strong>on</strong>g>less) <strong>23</strong>G cannula entry system<br />

• Up<strong>on</strong> removal <strong>of</strong> instrument from port, excessi<str<strong>on</strong>g>ve</str<strong>on</strong>g> and immediate emulsificaM<strong>on</strong> <strong>of</strong><br />

intra-­‐ocular perfluorocarb<strong>on</strong> liquid may be seen to occur (fig 1)<br />

• When val<str<strong>on</strong>g>ve</str<strong>on</strong>g>less cannulas are used in c<strong>on</strong>juncM<strong>on</strong> <strong>with</strong> IOP regulated infusi<strong>on</strong>, vast<br />

fluctuaM<strong>on</strong>s in infusi<strong>on</strong> pressure occur when a port is open. The resultant high<br />

<str<strong>on</strong>g>ve</str<strong>on</strong>g>locity fluid currents through the vitreous cavity ser<str<strong>on</strong>g>ve</str<strong>on</strong>g> to o<str<strong>on</strong>g>ve</str<strong>on</strong>g>rcome the surface<br />

tensi<strong>on</strong> <strong>of</strong> the tamp<strong>on</strong>ade agent.<br />

• <str<strong>on</strong>g>Emulsifica</str<strong>on</strong>g>M<strong>on</strong> <strong>of</strong> perfluorocarb<strong>on</strong> liquid presents an increased risk <strong>of</strong> incurring<br />

sub-­‐reMnal perfluorocarb<strong>on</strong> liquid droplets.<br />

Figure 1: <str<strong>on</strong>g>Emulsifica</str<strong>on</strong>g>+<strong>on</strong> <strong>of</strong> perfluorocarb<strong>on</strong> liquid up<strong>on</strong><br />

removal <strong>of</strong> instrument (val<str<strong>on</strong>g>ve</str<strong>on</strong>g>less <strong>23</strong>G cannula system).<br />

Direc+<strong>on</strong> <strong>of</strong> infusi<strong>on</strong> current (white arrows) and<br />

impressi<strong>on</strong> <strong>on</strong> surface <strong>of</strong> tamp<strong>on</strong>ade agent (asterisk).


Results<br />

Val<str<strong>on</strong>g>ve</str<strong>on</strong>g>d <strong>23</strong>G cannula entry system (Alc<strong>on</strong> Labs Inc.) (fig 2a and b)<br />

• Reduced incidence <strong>of</strong> perfluorocarb<strong>on</strong> liquid emulsificaM<strong>on</strong> up<strong>on</strong> removal <strong>of</strong><br />

instrument<br />

• StabilisaM<strong>on</strong> <strong>of</strong> infusi<strong>on</strong> pressure whilst port is open<br />

• Lower incidence <strong>of</strong> sub-­‐reMnal perfluorocarb<strong>on</strong> liquid droplets<br />

Figure 2a: Alc<strong>on</strong> <strong>23</strong>G val<str<strong>on</strong>g>ve</str<strong>on</strong>g>d Figure 2b: Alc<strong>on</strong> <strong>23</strong>G val<str<strong>on</strong>g>ve</str<strong>on</strong>g>d cannula (note<br />

cannula entry system setup external silic<strong>on</strong>e membranous val<str<strong>on</strong>g>ve</str<strong>on</strong>g>)


C<strong>on</strong>clusi<strong>on</strong>s<br />

• Certain features <strong>of</strong> c<strong>on</strong>temporary <strong>23</strong>G vitrectomy systems, such as val<str<strong>on</strong>g>ve</str<strong>on</strong>g>less trocar<br />

cannulas in c<strong>on</strong>juncM<strong>on</strong> <strong>with</strong> IOP regulated infusi<strong>on</strong>, promote increased flow <strong>of</strong><br />

fluid across the vitreous cavity and predispose to emulsificaM<strong>on</strong> <strong>of</strong> perfluorocarb<strong>on</strong><br />

liquid during instrument removal/exchange. Awareness <strong>of</strong> this phenomen<strong>on</strong> is<br />

parMcularly important when operaMng <strong>on</strong> eyes which are at increased risk <strong>of</strong><br />

incurring sub-­‐reMnal perfluorocarb<strong>on</strong> liquid droplets (e.g. giant reMnal tears and<br />

proliferaM<str<strong>on</strong>g>ve</str<strong>on</strong>g> vitreoreMnopathy). We suggest the following steps to reduce intra-­‐<br />

operaM<str<strong>on</strong>g>ve</str<strong>on</strong>g> perfluorocarb<strong>on</strong> liquid emulsificaM<strong>on</strong>:<br />

– Use <strong>of</strong> val<str<strong>on</strong>g>ve</str<strong>on</strong>g>d trocar cannula system<br />

– ReducM<strong>on</strong> <strong>of</strong> infusi<strong>on</strong> rate (where val<str<strong>on</strong>g>ve</str<strong>on</strong>g>less cannulas are used)<br />

– Opt to o<str<strong>on</strong>g>ve</str<strong>on</strong>g>r-­‐ride IOP regulated infusi<strong>on</strong> feature (where val<str<strong>on</strong>g>ve</str<strong>on</strong>g>less cannulas are used)<br />

• We suggest that the advantages <strong>of</strong> IOP regulated infusi<strong>on</strong> may <strong>on</strong>ly be fully<br />

realized when used in c<strong>on</strong>junc1<strong>on</strong> <strong>with</strong> newer val<str<strong>on</strong>g>ve</str<strong>on</strong>g>d cannula entry systems. We<br />

ha<str<strong>on</strong>g>ve</str<strong>on</strong>g> found that val<str<strong>on</strong>g>ve</str<strong>on</strong>g>d cannulas <strong>of</strong>fer se<str<strong>on</strong>g>ve</str<strong>on</strong>g>ral addiM<strong>on</strong>al advantages (Box 1), and<br />

highlight unique issues regarding surgical technique when adopMng a val<str<strong>on</strong>g>ve</str<strong>on</strong>g>d<br />

cannula entry system (Box 2)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!